We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Biotest AG (BIO) NPV

Sell:€42.40 Buy:€43.00 Change: €0.40 (0.94%)
Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

Biotest AG NPV

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 4 Jun 2025)

The boards of Biotest AG and Grifols Biotest Holdings GmbH recently announced the terms of a takeover. Under the terms of the takeover you have been offered EUR43.00 for each share held.

 

If you don’t want to sell any shares, you don’t need to do anything.

 

It is expected that the company's shares will be delisted from the Frankfurt Stock Exchange within 10 business days following the completion of this offer. Please note that if you do not accept this offer, it may be difficult to sell your shares in future, and in some cases, it may be impossible.

 

Accept the offer – Act by noon on Wednesday 4 June 2025

 

Any shares you ask to sell will be removed from your portfolio from 4 June 2025. Cash from any shares successfully sold will be converted from Euros to Pound Sterling upon receipt, based on the prevailing exchange rate at the time and our standard currency conversion fees, and credited to your account. Any shares not successfully sold will be returned to your account around the same time.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter/message and not on the summary information outlined above.

×
Sell:€42.40
Buy:€43.00
Change: €0.40 (0.94%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

Biotest AG NPV

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 4 Jun 2025)

The boards of Biotest AG and Grifols Biotest Holdings GmbH recently announced the terms of a takeover. Under the terms of the takeover you have been offered EUR43.00 for each share held.

 

If you don’t want to sell any shares, you don’t need to do anything.

 

It is expected that the company's shares will be delisted from the Frankfurt Stock Exchange within 10 business days following the completion of this offer. Please note that if you do not accept this offer, it may be difficult to sell your shares in future, and in some cases, it may be impossible.

 

Accept the offer – Act by noon on Wednesday 4 June 2025

 

Any shares you ask to sell will be removed from your portfolio from 4 June 2025. Cash from any shares successfully sold will be converted from Euros to Pound Sterling upon receipt, based on the prevailing exchange rate at the time and our standard currency conversion fees, and credited to your account. Any shares not successfully sold will be returned to your account around the same time.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter/message and not on the summary information outlined above.

×
Sell:€42.40
Buy:€43.00
Change: €0.40 (0.94%)
Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

Biotest AG NPV

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 4 Jun 2025)

The boards of Biotest AG and Grifols Biotest Holdings GmbH recently announced the terms of a takeover. Under the terms of the takeover you have been offered EUR43.00 for each share held.

 

If you don’t want to sell any shares, you don’t need to do anything.

 

It is expected that the company's shares will be delisted from the Frankfurt Stock Exchange within 10 business days following the completion of this offer. Please note that if you do not accept this offer, it may be difficult to sell your shares in future, and in some cases, it may be impossible.

 

Accept the offer – Act by noon on Wednesday 4 June 2025

 

Any shares you ask to sell will be removed from your portfolio from 4 June 2025. Cash from any shares successfully sold will be converted from Euros to Pound Sterling upon receipt, based on the prevailing exchange rate at the time and our standard currency conversion fees, and credited to your account. Any shares not successfully sold will be returned to your account around the same time.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter/message and not on the summary information outlined above.

×
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
€42.00
Trade high:
€42.00
Year high:
€42.80
Market capitalisation
Market cap.
:
€1.44 bn
Previous close:
€42.40
Trade low:
€42.00
Year low:
€40.00
Shares in issue
Shares
:
39.57 m
Previous:
€0.40 (0.93%) Previous:
€0.40
Volume:
n/a
Dividend yield:
0.00%
Currency:
EUR
Data delayed by at least 15 minutes.

Share chart Chart

BIOTEST ORD performance chart

Fundamental data

Year ending: 31/12/2012 31/12/2011
Revenue (€m) 439.97 422.03
Profit before tax (€m) 36.48 28.58
Adjusted EPS (¢): 64.67 52.33
P/E ratio n/a n/a
PEG n/a n/a
EPS growth (%) 24.00 (4.00)
Total dividend: n/a n/a
Dividend yield (%): 0.00 0.00
Dividend cover: 3.88 3.57

Values are quoted in the stock's local currency: Euro

All fundamental data

Ready to invest?

Invest now

Want to invest?

To buy shares in , you'll need to have an account.

Explore the options

Important Documents

There are no documents available for this stock.

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by Reuters. Charts provided by Factset. News and fundamental data provided by Digital Look. Exchange disclaimer
Thomson Reuters Logo

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.